HIV latency is influenced by regions of the viral genome outside of the long terminal repeats and regulatory genes

Virology

Volumn 417, Issue 2, 2011, Pages 394-399

  Marsden, Matthew D ^a   Burke, Bryan P ^a   Zack, Jerome A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Accessory genes; HIV; Latency; Model; Reporter virus; Thymocyte

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; REV GENE; TAT GENE; THYMOCYTE; VIRUS ACTIVATION; VIRUS GENE; VIRUS GENOME; VIRUS LATENCY; VIRUS TRANSCRIPTION;

CELL LINE; GENOME, VIRAL; HIV; HUMANS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS LATENCY;

EID: 80051953789     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.06.024     Document Type: Article

References (36)

1. An D.S., Morizono K., Li Q.X., Mao S.H., Lu S., Chen I.S. An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication. J. Virol. 1999, 73(9):7671-7677.
2. Arlen P.A., Brooks D.G., Gao L.Y., Vatakis D., Brown H.J., Zack J.A. Rapid expression of human immunodeficiency virus following activation of latently infected cells. J. Virol. 2006, 80(3):1599-1603.
3. Baur A.S., Sass G., Laffert B., Willbold D., Cheng-Mayer C., Peterlin B.M. The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 1997, 6(3):283-291.
4. Bosque A., Planelles V. Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood 2009, 113(1):58-65.
5. Brooks D.G., Zack J.A. Effect of latent human immunodeficiency virus infection on cell surface phenotype. J. Virol. 2002, 76(4):1673-1681.
6. Brooks D.G., Kitchen S.G., Kitchen C.M., Scripture-Adams D.D., Zack J.A. Generation of HIV latency during thymopoiesis. Nat. Med. 2001, 7(4):459-464.
7. Brooks D.G., Arlen P.A., Gao L., Kitchen C.M., Zack J.A. Identification of T cell-signaling pathways that stimulate latent HIV in primary cells. Proc. Natl Acad. Sci. U. S. A. 2003, 100(22):12955-12960.
8. Brooks D.G., Hamer D.H., Arlen P.A., Gao L., Bristol G., Kitchen C.M., Berger E.A., Zack J.A. Molecular characterization, reactivation, and depletion of latent HIV. Immunity 2003, 19(3):413-423.
9. Burke B., Brown H.J., Marsden M.D., Bristol G., Vatakis D.N., Zack J.A. Primary cell model for activation-inducible human immunodeficiency virus. J. Virol. 2007, 81(14):7424-7434.
10. Chiu Y.L., Soros V.B., Kreisberg J.F., Stopak K., Yonemoto W., Greene W.C. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 2005, 435(7038):108-114.
11. Chun T.W., Carruth L., Finzi D., Shen X., DiGiuseppe J.A., Taylor H., Hermankova M., Chadwick K., Margolick J., Quinn T.C., Kuo Y.H., Brookmeyer R., Zeiger M.A., Barditch-Crovo P., Siliciano R.F. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997, 387(6629):183-188.
12. Connor R.I., Chen B.K., Choe S., Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995, 206(2):935-944.
13. Emiliani S., Van Lint C., Fischle W., Paras P., Ott M., Brady J., Verdin E. A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proc. Natl Acad. Sci. U. S. A. 1996, 93(13):6377-6381.
14. Emiliani S., Fischle W., Ott M., Van Lint C., Amella C.A., Verdin E. Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line. J. Virol. 1998, 72(2):1666-1670.
15. Finzi D., Blankson J., Siliciano J.D., Margolick J.B., Chadwick K., Pierson T., Smith K., Lisziewicz J., Lori F., Flexner C., Quinn T.C., Chaisson R.E., Rosenberg E., Walker B., Gange S., Gallant J., Siliciano R.F. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 1999, 5(5):512-517.
16. Folks T.M., Justement J., Kinter A., Dinarello C.A., Fauci A.S. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987, 238(4828):800-802.
17. Folks T.M., Clouse K.A., Justement J., Rabson A., Duh E., Kehrl J.H., Fauci A.S. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl Acad. Sci. U. S. A. 1989, 86(7):2365-2368.
18. Han Y., Wind-Rotolo M., Yang H.C., Siliciano J.D., Siliciano R.F. Experimental approaches to the study of HIV-1 latency. Nat. Rev. Microbiol. 2007, 5(2):95-106.
19. Jordan A., Bisgrove D., Verdin E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 2003, 22(8):1868-1877.
20. Kim Y.K., Bourgeois C.F., Pearson R., Tyagi M., West M.J., Wong J., Wu S.Y., Chiang C.M., Karn J. Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency. EMBO J. 2006, 25(15):3596-3604.
21. Korin Y.D., Brooks D.G., Brown S., Korotzer A., Zack J.A. Effects of prostratin on T-cell activation and human immunodeficiency virus latency. J. Virol. 2002, 76(16):8118-8123.
22. Marsden M.D., Zack J.A. Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo. J. Virol. 2007, 81(11):6146-6150.
23. Marsden M.D., Zack J.A. Eradication of HIV: current challenges and new directions. J. Antimicrob. Chemother. 2009, 63(1):7-10.
24. Marsden M.D., Zack J.A. Establishment and maintenance of HIV latency: model systems and opportunities for intervention. Future Virol. 2010, 5(1).
25. McCune J.M., Namikawa R., Kaneshima H., Shultz L.D., Lieberman M., Weissman I.L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988, 241(4873):1632-1639.
26. Naldini L., Blomer U., Gage F.H., Trono D., Verma I.M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl Acad. Sci. U. S. A. 1996, 93(21):11382-11388.
27. Namikawa R., Weilbaecher K.N., Kaneshima H., Yee E.J., McCune J.M. Long-term human hematopoiesis in the SCID-hu mouse. J. Exp. Med. 1990, 172(4):1055-1063.
28. Renkema G.H., Manninen A., Saksela K. Human immunodeficiency virus type 1 Nef selectively associates with a catalytically active subpopulation of p21-activated kinase 2 (PAK2) independently of PAK2 binding to Nck or beta-PIX. J. Virol. 2001, 75(5):2154-2160.
29. Sahu G.K., Lee K., Ji J., Braciale V., Baron S., Cloyd M.W. A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes. Virology 2006, 355(2):127-137.
30. Scripture-Adams D.D., Brooks D.G., Korin Y.D., Zack J.A. Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J. Virol. 2002, 76(24):13077-13082.
31. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418(6898):646-650.
32. Simmons A., Aluvihare V., McMichael A. Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity 2001, 14(6):763-777.
33. Uittenbogaart C.H., Anisman D.J., Zack J.A., Economides A., Schmid I., Hays E.F. Effects of cytokines on HIV-1 production by thymocytes. Thymus 1994, 23(3-4):155-175.
34. Van Lint C., Ghysdael J., Paras P., Burny A., Verdin E. A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J. Virol. 1994, 68(4):2632-2648.
35. Weinberger L.S., Burnett J.C., Toettcher J.E., Arkin A.P., Schaffer D.V. Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 2005, 122(2):169-182.
36. Wong J.K., Hezareh M., Gunthard H.F., Havlir D.V., Ignacio C.C., Spina C.A., Richman D.D. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997, 278(5341):1291-1295.